Embracing the Digital Era
From LIMS to AI, connected technologies are becoming a strategic initiative for an increasing number of smart companies
Laura Marozsan | | Opinion
Substantial evidence of pharma’s shift towards digitization can be seen by the increasing number of “chief digital officer” appointments or similar across big pharmaceutical companies as they look to strategically boost digital capabilities. Advanced digital technologies, such as laboratory information management systems (LIMS), the Internet of Things, artificial intelligence, and machine learning, with its subset, deep learning, are all becoming hot topics in the industry.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine